Related Experiment Videos
ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response
Basak Icli1, Ajit Bharti, Laura Pentassuglia
1Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
The intracellular domain of ErbB4 receptor tyrosine kinase is known to translocate to the nucleus of cells where it can regulate p53 transcriptional activity. The purpose of this study was to examine whether ErbB4 can localize to the nucleus of adult rat ventricular myocytes (ARVM), and regulate p53 in these cells. We demonstrate that ErbB4 does locate to the nucleus of cardiac myocytes as a full-length protein, although nuclear location occurs as a full-length protein that does not require Protein Kinase C or γ-secretase activity. Consistent with this we found that only the non-cleavable JM-b isoform of ErbB4 is expressed in ARVM. Doxorubicin was used to examine ErbB4 role in regulation of a DNA damage response in ARVM. Doxorubicin induced p53 and p21 was suppressed by treatment with AG1478, an EGFR and ErbB4 kinase inhibitor, or suppression of ErbB4 expression with small interfering RNA. Thus ErbB4 localizes to the nucleus as a full-length protein, and plays a role in the DNA damage response induced by doxorubicin in cardiac myocytes.
Insights
Full-length ErbB4 receptor tyrosine kinase translocates to the nucleus of cardiac myocytes, regulating the DNA damage response. This nuclear localization of ErbB4 is crucial for p53 and p21 regulation following doxorubicin treatment.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- ErbB4 receptor tyrosine kinase intracellular domain translocates to the nucleus, regulating p53.
- The role of ErbB4 in cardiac myocytes and its nuclear localization is not well understood.
Purpose of the Study:
- To investigate if ErbB4 localizes to the nucleus of adult rat ventricular myocytes (ARVM).
- To determine if ErbB4 regulates p53 transcriptional activity in ARVM.
Main Methods:
- Immunofluorescence to confirm nuclear localization of full-length ErbB4 in ARVM.
- Western blotting to analyze p53 and p21 expression.
- Doxorubicin treatment to induce DNA damage response.
- Inhibition of ErbB4 kinase activity with AG1478.
- Suppression of ErbB4 expression using small interfering RNA (siRNA).
Main Results:
- Full-length ErbB4 was found to localize in the nucleus of ARVM.
- Nuclear localization of ErbB4 did not require Protein Kinase C or γ-secretase activity.
- Only the non-cleavable JM-b isoform of ErbB4 was expressed in ARVM.
- Doxorubicin-induced p53 and p21 expression was suppressed by AG1478 or ErbB4 siRNA.
- ErbB4 plays a role in the DNA damage response in cardiac myocytes.
Conclusions:
- ErbB4 localizes to the nucleus of cardiac myocytes as a full-length protein.
- ErbB4 plays a significant role in the DNA damage response pathway in cardiac myocytes, specifically in regulating p53 and p21.
- The non-cleavable JM-b isoform of ErbB4 is responsible for these nuclear functions in ARVM.
Related Concept Videos
MAPK Signaling Cascades
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Negative Regulator Molecules
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal